Metropolis Healthcare Ltd (MHL), one of India’s top diagnostics chains, is set for major growth. Ameera Shah, the company’s promoter and executive chairperson, shared that Metropolis plans to acquire 2–3 companies every year, mainly in North and East India, to expand its presence and focus on specialty diagnostics.
Focus on High-End Specialty Testing
Metropolis is now putting more emphasis on specialized tests in areas such as:
✅ Oncology (cancer diagnostics)
✅ Neurology
✅ Nephrology (kidney care)
✅ Gastroenterology
✅ Gynaecology
✅ Infectious diseases
These areas are vital in modern medicine, and Metropolis aims to lead by offering advanced diagnostic services supported by molecular platforms and AI-driven tools.
How Will Metropolis Fund These Acquisitions?
Ameera Shah highlighted that Metropolis is debt-free and generates around ₹200–300 crore in cash annually. This strong financial position allows the company to self-fund acquisitions and invest in the latest technology and infrastructure.
Strategic Expansion Across India
Metropolis already has a strong presence in West and South India, and with its recent acquisitions of:
- Core Diagnostics (Delhi NCR – specialized in cancer testing)
- Scientific Pathology (Agra)
…the company is growing its presence in North India. Revenue from the North is expected to increase from 8% to 13–14% by FY26.
In the next financial year, the company aims to:
- Increase revenue to ₹1,700–1,750 crore (from ₹1,300–1,350 crore this year)
- Add 100 new towns, especially tier 2 and 3 cities
- Open 800 new collection centres
- Set up new diagnostic labs
Strengthening Infrastructure with Capex Investment
Metropolis is planning to invest ₹75–150 crore over the next two years in:
- Expanding its high-end specialty diagnostics
- Upgrading labs with automation for faster turnaround
- Streamlining operations to improve patient care and reduce costs
This will help retain leadership in the South and West while gaining ground in North and East India.
“Our mission is to make high-quality, specialized testing more accessible across India,” says Ameera Shah.
To register for our next masterclass please click here https://linktr.ee/docpreneur
